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Abstract
 
Infants experiencing severe respiratory syncytial virus (RSV) bronchiolitis have an increased fre-
quency of wheeze and asthma in later childhood. Since most severe RSV infections occur be-
tween the 8th and 24th postnatal week, we examined whether age at first infection determines
the balance of cytokine production and lung pathology during subsequent rechallenge. Primary
RSV infection in newborn mice followed the same viral kinetics as in adults but was associated
with reduced and delayed IFN-
 
 
 
 responses. To study rechallenge, mice were infected at 1 day or
1, 4, or 8 weeks of age and reinfected at 12 weeks. Neonatal priming produced more severe
weight loss and increased inflammatory cell recruitment (including T helper 2 cells and eosino-
phils) during reinfection, whereas delayed priming led to enhanced interferon 
 
 
 
 production and
less severe disease during reinfection. These results show the crucial importance of age at first in-
fection in determining the outcome of reinfection and suggest that the environment of the neo-
natal lung is a major determinant of cytokine production and disease patterns in later life. Thus,
simply delaying RSV infection beyond infancy might reduce subsequent respiratory morbidity in
later childhood.
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Introduction
 
Although perinatal antigen exposure sometimes leads to T
cell tolerance, neonates can generate immune responses to
some vaccines and antigens, depending on the dose and the
route of delivery (1–3). However, neonates tend to display
Th2-biased responses with prolonged memory, whereas
Th1 memory is unstable (4–6) and neonatal vaccination is
often unsuccessful (7).
 
Respiratory syncytial virus (RSV) infects 
 
 
 
65% of chil-
dren in the first year of life and causes most cases of viral
bronchiolitis, the risk of which peaks at 2–6 mo of age (8).
Severe infantile RSV infections are associated with recurrent
wheezing and asthma diagnosis in later life (9), an effect
which lasts 10–12 yr. Infants with bronchiolitis exhibit
Th2-biased responses to nonspecific PBMC stimulation
both during and after infection (10), and peripheral T cells
from 7–8-yr-old children with a history of bronchiolitis fre-
quently make IL-4 after stimulation with RSV in vitro (11).
We suspected that age at first infection might play a key
role in shaping later immune responses. Since RSV regu-
larly reinfects older children and adults (causing common
colds, exacerbating preexisting lung disease and contributing
to winter respiratory morbidity and mortality in the el-
derly), we studied the effects of age at first infection on re-
infection in mice. We show that the timing of neonatal
infection establishes the subsequent pattern of T cell re-
sponses and, consequently, the nature and severity of dis-
ease during of reinfection in adulthood.
 
Materials and Methods
 
Mice and Viral Stocks.
 
BALB/c mice (Harlan Olac Ltd.) were
maintained in individual filter cages. Pregnant mice were pur-
chased at 
 
 
 
14 d gestation and pups weaned at 3 wk. RSV A2
strain was grown in HEp-2 cells and the viral titre determined by
plaque assay. Mice were infected intranasally at 1, 7, 28, or 56 d of
age with 4 
 
 
 
 10
 
4
 
 PFU of RSV per g body weight. In 1- and 7-d
mice, virus was instilled without anesthesia in 5 or 10 
 
 
 
l, and
mice gently restrained until inhalation occurred. Older mice were
lightly anaesthetized with isofluorane. All mice were reinfected at
12 wk of age. All work was approved and licensed appropriately.
 
Recovery of Cells.
 
7 d after rechallenge, mice were terminally
anaesthetised and exsanguinated via femoral vessels. Lungs were
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inflated via the trachea five times with 1 ml EBSS with 12 mM
lidocaine; 100 
 
 
 
l of lavage was spun onto glass slides, air dried,
and stained with H&E. Viable cells were counted with Trypan
blue. For whole lung cell preparation, lungs were pressed
through 100-
 
 
 
m mesh, RBC lysed, and cells washed.
 
Flow Cytometry for Intracellular Cytokines.
 
Lung cells were
stimulated with PMA and ionomycin and stained with combina-
tions of CD4-Tricolor (RM4–5), CD8-FITC (5H10) (Caltag), IL-
5-PE (TRFK-5), IL-10-PE (JES5–16E3), IFN-
 
 
 
-PE (XMG1.2),
and IL-4-PE (11B11) (BD PharMingen) before analysis on a FACS-
calibur™ (Becton Dickenson) (12). Lymphocytes were gated for
according to their forward and side scatter properties: the percent-
age that stained for CD4 or CD8 and the percentage of these
groups that expressed particular cytokines was determined.
 
CTL Responses.
 
CTL responses were measured from mice
infected at 1 or 8 wk old as described previously (13). In brief,
splenocytes were grown for 6 d with 1 
 
 
 
M of RSV M2 82–90
peptide and IL-2; CTL activity was tested against peptide-pulsed
P815 targets.
 
Quantification of Viral and Cytokine RNA.
 
RNA was ex-
tracted from the lung with RNA-Stat 60 (Tel-Test Inc.) and
cDNA generated with random hexamers using an Omniscript
RT-kit (QIAGEN). PCR specific for RSV L gene was per-
formed at 50
 
 
 
C for 2 min and 95
 
 
 
C for 10 min followed by 40
two-step cycles (15 s at 95
 
 
 
C, 1 min at 60
 
 
 
C) using Universal
PCR Mastermix (Applied Biosystems) and 900 nM forward primer
(5
 
 
 
-GAACTCAGTGTAGGTAGAATGTTTGCA-3
 
 
 
), 300 nM
reverse primer (5
 
 
 
-TTCAGCTATCATTTTCTCTGCCAAT-3
 
 
 
),
and 100 nM probe (5
 
 
 
-FAM-TTTGAACCTGTCTGAACAT-
TCCCGGTT-TAMRA-3
 
 
 
). Copy number was determined
from standard curves of PCDNA3 plasmid vector containing a
fragment of the RSV L-gene (gift of C. Ward). For IFN-
 
 
 
mRNA, PCR was performed as described previously (14), but
with Universal PCR Mastermix, quantified relative to a single
positive control. Taqman GAPDH Control Reagents (Applied
Biosystems) confirmed equal quantities of input cDNA, and PCR
amplifications were measured in real time using the ABI 7700
(Applied Biosystems) and analyzed using Sequence Detections
Systems (v1.6.3).
Statistical significances were assessed by ANOVA.
 
Results
 
Mice were infected with RSV as neonates (1 or 7 d
old), as young mice (4 wk) or as young adults (8 wk) and
rechallenged in adulthood (12 wk of age). Mice infected as
neonates developed severe illness during rechallenge,
weight loss peaking at 18% on day 6. By contrast, mice
first infected in later life (or undergoing primary adult in-
fection) exhibited only minor (
 
 
 
5%) weight loss (P 
 
 
 
0.0001; Fig. 1).
To see how primary infection was affected by age, 7-d
pups and 8-wk mice were infected. Pups continued to
thrive during primary infection, gaining weight at an equal
rate to those that had received UV-inactivated RSV (Fig. 2
a), whereas young adult mice suffered slight weight loss
(Fig. 2 b). Although the pup’s lungs were smaller than
those of adults, they contained similar numbers of cells and
did not greatly increase in cellularity during primary infec-
tion (1.9 
 
 
 
 0.7 in uninfected vs. 2.27 
 
 
 
 0.3 
 
 
 
 10
 
6
 
 in 7-d–
infected pups), whereas there was an increase in pulmonary
 
cellularity during primary infection in adults (1.7 
 
 
 
 0.5 vs.
3.4 
 
 
 
 0.8 
 
 
 
 10
 
6
 
).
Copy number of RSV L-gene RNA was lower in pups
than adults, but peaked on day 4 and declined similarly re-
gardless of age. (Fig. 2 c). However, IFN-
 
 
 
 mRNA levels
were reduced and delayed in pups (Fig. 2 d), reflected also
in CD4
 
 
 
 cells staining for intracellular IFN-
 
 
 
 (neonates,
day 2: 0.9 
 
  
 
1.0%; day 4: 0.5 
 
 
 
 0.3%; day 7: 5.4 
 
 
 
 0.9%;
adults, day 2: 1.6 
 
 
 
 0.6%; day 4: 4.7
 
  
 
 1.8%; day 7: 13.4 
 
 
 
6.2%). To confirm CTL priming in neonates, mice in-
fected at 1 or 8 wk were killed after 3 wk or at 11 wk of
age and CTL isolated from splenocytes. In either case,
RSV-specific CTL were found (but were absent from mice
given UV-inactivated RSV), confirming immunological
CTL priming dependent on virus infection.
During reinfection, mice first infected at 1 d recruited the
most cells to the lung (Fig. 3 a), showing that increased
weight loss reflected greater lung inflammation. In both the
lung and the bronchoalveolar lavage (BAL), mice first in-
fected at 1 d or 1 wk recruited relatively more CD8
 
 
 
 T cells
and fewer CD4
 
 
 
 T cells to the lung during rechallenge (Fig.
3, b and c). Cytospin preparations of the BAL fluid showed
striking pulmonary eosinophilia upon reinfection, which
was greatest in neonates first infected at 1 d of age (P 
 
 
 
 0.05;
Fig. 4 a). All groups developed a neutrophilia after secondary
challenge, but it was most marked in those first infected
when very young (Fig. 4 b). Neutrophil numbers in mice
first infected at 1 d or 1 wk of age were not significantly dif-
ferent, but were significantly higher than those first infected
later in life (P 
 
  
 
0.05 at 4 wk and P 
 
  
 
0.01 at 8 wk).
To determine whether the interval between priming
and challenge accounted for the results, mice were in-
Figure 1. Age at primary infection determines weight loss after secondary
challenge. Mice were weighed daily after RSV rechallenge at 12 wk of age.
Groups had been previously infected at 1 d (black squares), 1 (black trian-
gles), 4 (inverted black triangles), or 8 wk (black circles) of age or had not
previously been challenged (white circles). Data is normalised to group
weight at challenge and shown as mean   SEM. Weight loss in groups first
infected as pups were significantly lower on day 3 (P   0.01) and days 4–7
(P   0.0001). There was no significant difference between groups first in-
fected after weaning (4 wk, 8 wk, or no primary infection) and no differ-
ence between groups first infected as pups (1 d or 1 wk primary) (P   0.05). 
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fected at 1 wk and then reinfected at 4 wk, comparison
being made with mice first infected at 8 wk then rein-
fected at 11 wk (i.e., the interval between primary and
secondary infection was maintained at 3 wk). Mice first
infected as pups developed a severe weight loss after re-
challenge, loosing 20.7 
 
 
 
 10.9% weight and developing
pulmonary eosinophilia (5.8 
 
 
 
 4.3% of BAL cells), which
was absent in mice first infected at 8 wk or undergoing
primary infection as adults. Therefore, the critical factor is
age of primary infection rather than interval between pri-
mary infection and rechallenge. Mice receiving UV-inac-
tivated RSV as neonates did not develop severe weight
loss during secondary challenge (unpublished data), show-
ing that live viral infection was necessary for priming the
augmented responses.
Intracellular staining of lung lymphocytes showed that
the proportion of CD4
 
 
 
 lymphocytes expressing IFN-
 
 
 
during reinfection increased with age at first infection. In-
tracellular IL-4 showed a reverse trend (Figs. 5 and 4, c and
d). IL-10 followed a similar pattern to IFN-
 
 
 
, but the dif-
ference between groups did not reach significance (unpub-
lished data). By contrast, the proportion of IFN-
 
 
 
 
 
 
 
CD8
 
 
 
cells was unaffected by the age of primary infection (Fig. 4
e) and very few (
 
 
 
1%) stained for IL-4 (Fig. 4 f) or IL-10
(unpublished data) in any situation.
 
Discussion
 
Our results show that the age of primary infection with
RSV has a profound effect on the outcome of RSV rechal-
lenge and that weight loss during rechallenge is driven by
inappropriate immune responses primed by infection in
early life. The stronger inflammatory response during rein-
fection in mice first infected as pups was not due to a stron-
ger response during primary infection, nor to higher viral
replication and delayed clearance, but to immune-driven
disease augmentation.
The strongest Th2 responses were seen in mice primed
at the youngest age, suggesting that the eosinophilic lung
disease seen in adults primed as neonates is likely to be
caused by CD4 T cells making type 2 cytokines. Others
have suggested a role for IL-5–producing CD8
 
 
 
 (Tc2) cells
in driving Th2 responses to RSV (15), but we found no
evidence for Tc2 cells in our model. Had neonates failed to
generate a CTL response, this might have explained the
subsequent eosinophilia, since we and others have previ-
ously shown that CD8
 
 
 
 T cells and NK cells making IFN-
 
 
 
play a role in preventing it (16, 17). However, neonatal and
adult mice both developed good CTL responses after pri-
mary infection and the proportion of CD8
 
 
 
 cells during
Figure 3. Age at primary infection determines inflammatory cell recruitment after secondary challenge. Mice were infected with RSV at either 1 d, 1,
4, or 8 wk of age and rechallenged at 12 wk of age. On day 7 after secondary challenge, viable cell numbers in bronchoalveolar lavage were significantly
higher in mice first infected at 1 day of age than in mice first infected as adults (P   0.01). Primary infection as neonates (1 d of age or 1 wk of age) re-
sulted in a significantly higher proportion of CD8  cells (P   0.01) recruited to the lung after secondary infection (b), and a lower proportion of CD4 
cells (P   0.001) (c). There was no significant difference between groups first infected after weaning (4 wk or 8 wk) and no difference between groups
first infected as pups (1 d or 1 wk primary) (P   0.05).
Figure 2. Primary RSV infection. Mice were infected at 1 or 8 wk old
and weighed daily for 7 d. In neonates, each litter was weighed and the
average weight per pup in each litter calculated (a). Data shows the aver-
age of three litters, either RSV (black squares) or UV-RSV (white
squares) challenged. Average weight of adult mice (b) either RSV (black
circles) or UV-RSV (white circles) challenged. Copy number of RSV
L-gene RNA (c) or relative IFN-  mRNA production (d) was deter-
mined by RT-PCR on whole lung from mice infected at 1 (black
squares) or 8 wk of age (black circles) or in 1-wk-old mice challenged
with UV-inactivated RSV (white squares). 
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Figure 5. FACS® analysis of intracellular cytokine production during secondary infection. Lung cells were surface stained for CD4 and intracellular cy-
tokine staining performed for IFN-  and IL-4. The proportion of total lymphocytes staining for IL-4 production is greatest in pups first infected at 1 d of
age, and the majority of this cytokine is within the CD4  population. Conversely, the proportion of lymphocytes staining for IFN-  increases with in-
creasing age at primary infection. In pups infected as neonates the IFN-  production is approximately equally distributed between CD4  and CD4  cells.
However, in mice first infected at 4 or 8 wk, CD4  cells account for a higher proportion of the IFN- –producing cells.
Figure 4. Cell recruitment to the lung after secondary
infection. Eosinophil numbers in the BAL were greatest in
neonates first infected at 1 d old (P   0.05) and eosino-
philia was absent in mice first infected at 4 or 8 wk of age
(a). Neutrophil numbers also declined with age at primary
infection (b). Lung cell suspensions were stained for CD4
or CD8 and the cytokines IFN-  and IL-4. Data is ex-
pressed as the mean proportion of CD4  and CD8  cells
staining for each cytokine   SD. There were significantly
fewer CD4  IFN-   cells in mice first infected as neonates
than in those first infected at 4 or 8 wk of age (c; P  
0.001 and P   0.01, respectively). Conversely, intracellular
IL-4 staining decreased with increasing age at primary in-
fection: Mice first infected at 1-d-old exhibited the greatest
proportion of IL-4  CD4  cells (d; P   0.05). The pro-
portion of CD8  cells staining for each of the cytokines did
not differ significantly with the age at primary infection (e
and f). 
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adult reinfection decreased as age at first infection in-
creased. Moreover, the proportion of IFN-
 
 
 
 
 
 CD8
 
 
 
 cells
was unaffected by the age of primary infection.
In both mouse and man, primary RSV infection rarely leads
to pulmonary eosinophilia. However, adult BALB/c mice de-
velop a Th2 response to RSV after dermal scarification with re-
combinant vaccinia virus expressing the RSV G-protein (vvG)
(18) which primes a dominant population of V
 
 
 
14
 
 
 
 
 
CD4
 
 
 
cells specific for the 183–197 epitope (19, 20). Heightened T
cell responses are believed to underlie the cellular infiltrate seen
in younger children who received formalin-inactivated RSV
vaccine (21, 22), although heightened bronchial reactivity may
have been related to immune complex deposition and comple-
ment activation (23).
Bronchiolitis may be the first manifestation of a predis-
position to recurrent respiratory disorders or severe RSV
disease may lead directly to chronic, persistent, or delayed
disease. Our current studies show that disease enhancing
responses can be induced by normal exposure to live RSV
if infection occurs in the early postnatal period. This find-
ing supports the proposition that the delayed effects of in-
fantile bronchiolitis are acquired, and that neonatal RSV
infection could itself cause subsequent recurrent wheeze.
Infections in early life seem to play an important role in
shaping immunological development. According to the hy-
giene hypothesis, lack of exposure to Th1-promoting patho-
gens (or their components) contributes to the rise in the inci-
dence of allergy and asthma (24). Existing T cell memory to
one respiratory viral infection has been shown to profoundly
alter the nature of the Th1/Th2 balance and dynamics of sub-
sequent infection with an antigenically unrelated virus (25, 26).
Therefore, it is possible that Th2-biased memory responses to
RSV may direct responses to other antigens in the lung toward
a more ‘allergic’ phenotype. Others have reported reduced and
delayed IFN-
 
 
 
 production after neonatal challenge with 
 
Pneu-
mocystis carinii 
 
and speculated that this was due to suppression of
T cell responses in the environment of the neonatal lung (27).
Our data suggest that such differences in neonatal immune re-
sponses can have long-lasting consequences for the host. We
suggest that a weaker Th1 response during primary infection
may allow the development of stronger Th2 responses to re-
challenge later in life, so explaining the enhanced disease, lym-
phocyte, and granulocyte recruitment in adult reinfection.
It is currently unclear whether the Th2 bias in the neona-
tal immune system is due to the T cells, their environment,
or both. For example, neonatal dendritic cells are deficient
in IL-12 production, an important factor in the differentia-
tion of Th1 cells (28) and respiratory tract dendritic cells are
less numerous and mature in the neonatal than in the adult
lung (29). The intrinsic properties of the T cell may differ in
neonates. For example, reduced IFN-  production by neo-
natal CD4  T cells may be explained by differential patterns
of methylation of the IFN-  promoter (30).
In conclusion, our results show that the timing of RSV
infection in newborn mice is a crucial factor in determining
the outcome of reinfection in adulthood and that early
neonatal infection is associated with long lasting bias to-
ward Th2 responses to rechallenge. Therefore, delaying
RSV infection might avoid the delayed consequences of
bronchiolitis, possibly reducing the frequency of respiratory
symptoms in later childhood. These novel findings high-
light the importance of early life infections in determining
subsequent patterns of disease and suggest that efforts
should be directed toward delaying RSV disease until chil-
dren are more immunologically mature.
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